Lilian Y. Zhou - 18 Jun 2026 Form 4 Insider Report for STAAR SURGICAL CO (STAA)

Reporting relationship: Director
Issuer ticker: STAA
Reported as of: 18 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 22 Jun 2026, 16:05:06 UTC
Prior SEC filing: 15 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Kathleen Determann as attorney-in-fact for Lilian Y. Zhou

Key filing fact

Lilian Y. Zhou filed Form 4 for STAAR SURGICAL CO (STAA) on 22 Jun 2026.

Key facts

This page summarizes Lilian Y. Zhou's Form 4 filing for STAAR SURGICAL CO (STAA).
2 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 22 Jun 2026, 16:05.

Change

Previous filing in this sequence was filed on 15 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002003105 Primary reporting owner

Zhou Lilian Yansheng

Relationship: Director
Address: 25510 COMMERCENTRE DRIVE, LAKE FOREST
Signature: /s/ Kathleen Determann as attorney-in-fact for Lilian Y. Zhou
Signature date: 22 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

STAA transaction Derivative

Restricted Stock Units

Award

Transaction value
Shares: +3,091
Change %
Price: $0.000000^*
Shares after: 3,091
Date: 18 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,091
Exercise price: $0.000000
Footnotes: F1

STAA transaction Derivative

Common Stock Options

Award

Transaction value
Shares: +5,572
Change %
Price: $0.000000^*
Shares after: 5,572
Date: 18 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 5,572
Exercise price: $29.12
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Reflects restricted stock units and options to purchase common stock granted to the Reporting Person on June 18, 2026, pursuant to the Issuer's annual non-employee director equity compensation program for the 2026-2027 term. These equity awards vest in full on the earlier of June 18, 2027 or the Issuer's 2027 Annual Meeting of Shareholders.

SEC remarks

This Form 4 reflects the equity awards granted to the Reporting Person on June 18, 2026 pursuant to Issuer's annual non-employee director equity compensation program for the 2026-2027 term.